Results 541-560 of 3,998 for speaker:Michael Harty

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: Is there an acceptable level of THC?

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: With regard to products that are or could be authorised, what level of THC is acceptable in cases where a licence is obtained?

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: If a patient travels abroad and is stabilised on a cannabis based product before returning to this country, is a distinction made between initiating a treatment in Ireland as opposed to maintaining somebody who is already on a medication?

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: Would the same licensing application process apply?

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: It will probably make up part of his answer, but before Dr. Devlin comes in I would like to ask if there is sufficient confidence in this report, or could consultants obtain sufficient confidence in this report to prescribe medicinal cannabis? If they cannot, and the consultant felt they were opening themselves to litigation by prescribing a product, could the Department indemnify a...

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: I thank Dr. Devlin. Deputy O'Connell wants to come back in.

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: I will ask one more question before we wind up. What criteria will be used to approve products? How will the HPRA go about approving products that will be used in the access programme? A product that suits one illness might not suit another in terms of the combination of CBD and THC. How will the HPRA adjudicate on this matter?

Joint Oireachtas Committee on Health: Cannabis for Medical Use: Discussion (7 Mar 2017)

Michael Harty: On behalf of the committee, I thank Dr. Breslin, Dr. Nolan, Mr. Lennon, Ms Egan, Dr. Devlin and Dr. Glynn for attending. I also thank those committee members who attended at short notice. As there is no other business, we will adjourn until tomorrow at 1.30 p.m.

Health (Amendment) Bill 2017: Second Stage (8 Mar 2017)

Michael Harty: I will also support the Bill as it is the start of progress. Reducing the prescription charge from €2.50 to €2 for those aged over 70 years and capping it at €20 per month is a start, although a very small start. When this prescription charge was introduced in 2010, it was 50 cent and it was meant to reduce unnecessary taking of drugs where people were getting drugs...

Misuse of Drugs (Supervised Injecting Facilities) Bill 2017: Second Stage (Resumed) (8 Mar 2017)

Michael Harty: Tonight, the House is witnessing a split in the Rural Independent Group because I will speak in favour of the Bill.

Misuse of Drugs (Supervised Injecting Facilities) Bill 2017: Second Stage (Resumed) (8 Mar 2017)

Michael Harty: The Bill appears to be counter-intuitive and perhaps my colleagues see it that way in that it appears to be encouraging drug misuse but, in fact, it has the opposite intention. The intent of the Bill is not in any way to condone intravenous drug abuse or to encourage illegal activity. Its intent is to reduce health risk for intravenous drug abusers. Such drug abuse is very high risk...

Misuse of Drugs (Supervised Injecting Facilities) Bill 2017: Second Stage (Resumed) (8 Mar 2017)

Michael Harty: It is a nationwide issue., not just a Dublin problem. The principle underlying this legislation is better outcomes for patients. It is primarily about saving their lives. Remember, we cannot rehabilitate someone who is dead. We must give them every support that we can. In terms of the policing aspect of this issue, it requires common sense policing. It requires a sensitive approach...

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: This afternoon we are meeting officials from the Department of Health to discuss Brexit. The purpose of the meeting is to discuss the implications for the health sector of the decision of the United Kingdom to withdraw from the European Union. On behalf of the committee, I welcome Mr. Muiris O'Connor, Mr. Fergal Goodman, Mr. Tom Monks, Mr. Kieran Smith and Ms Sarah Rose Flynn of the...

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: There was a question on the registration of doctors and nurses.

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: Will Mr. Goodman send that information to us when he gets it?

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: Will Mr. O'Connor send us that information as soon as it is available?

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: Deputy O'Connell, Senators Colm Burke and Dolan and Deputy Durkan are next.

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: Just to concentrate minds, I remind the committee that we have another meeting starting at 4 p.m.

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: There are many questions for the delegates. Deputy Kate O'Connell spoke specifically about delivery delays and timelines in drug importation. The delegates might deal with that issue first.

Joint Oireachtas Committee on Health: Implcations for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (8 Mar 2017)

Michael Harty: Will the negotiating stance be that the 26 countries should negotiate with the UK? Will it be a common negotiating stance?